Bank Of New York Mellon Corp 10x Genomics, Inc. Transaction History
Bank Of New York Mellon Corp
- $521 Trillion
- Q1 2024
A detailed history of Bank Of New York Mellon Corp transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Bank Of New York Mellon Corp holds 850,815 shares of TXG stock, worth $21.3 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
850,815
Previous 947,393
10.19%
Holding current value
$21.3 Million
Previous $53 Billion
39.77%
% of portfolio
0.01%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding TXG
# of Institutions
307Shares Held
92MCall Options Held
267KPut Options Held
62.1K-
Vanguard Group Inc Valley Forge, PA9.1MShares$228 Million0.01% of portfolio
-
Baillie Gifford & CO7.42MShares$186 Million0.22% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.28MShares$157 Million1.68% of portfolio
-
Black Rock Inc. New York, NY6.01MShares$150 Million0.01% of portfolio
-
Morgan Stanley New York, NY5.16MShares$129 Million0.02% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $2.38B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...